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Background: The prevalence of chronic kidney disease (CKD) and metabolic diseases has increased at different
rates in different regions in China. The aim of our study was to estimate the prevalence of CKD and to analyze
associated risk factors of CKD in Zhejiang province, Eastern China.
Methods: A cross-sectional survey of 11,013 adults was conducted from September 2009 to June 2012 in Zhejiang
Province, located in Eastern China. CKD was defined as having an estimated glomerular filtration rate (eGFR) <
60 mL/min/1.73 m2 or the presence of albuminuria. Medical history, physical examination and laboratory data were
used to diagnose metabolic diseases. Age- and sex-standardized prevalence was calculated using the data on the
population distribution in China in 2010. We examined risk factors associated with decreased renal function and
albuminuria using multivariate logistic regression.
Results: A total of 10,384 adults (94.3%) completed the screening. The standardized prevalence of reduced renal
function (eGFR < 60 mL/min/1.73 m2) was 1.83% (95% CI 1.52–2.13) and that of albuminuria was 8.65% (95% CI
7.98–9.31). The overall prevalence of CKD was 9.88% (95% CI 9.18–10.59). The prevalence of reduced renal function
was greater in the eastern rural areas in Zhejiang province. Multivariate logistic regression revealed that metabolic
diseases such as diabetes, obesity, hypertension, and hyperuricemia were independent risk factors of CKD. Patients
with metabolic diseases had a significantly (P < 0.001) higher prevalence of CKD than those without such diseases.
Conclusions: CKD has become a severe public health problem in Zhejiang Province, and metabolic diseases may
increase the risk of CKD in Zhejiang population.
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The prevalence of chronic kidney disease (CKD) and
metabolic diseases such as diabetes, obesity, hyperurice-
mia, hyperlipidemia and hypertension has increased and
has become leading public health problem [1,2]. China
is a developing country with more than 30 provinces,* Correspondence: chenjianghua@zju.edu.cn
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ported that the prevalence of chronic kidney disease var-
ied greatly between geographical regions [3]. This might
be related to variability in lifestyles and economic devel-
opment. As a populous and economically developed
province in eastern China, the permanent population of
Zhejiang reached 54.42 million at the end of 2010. How-
ever, there are few reports about the prevalence of CKD
in Zhejiang province.
Metabolic diseases such as diabetes, obesity and hyper-
tension are known to be risk factors of kidney injury,
and play an important role in the progression of CKD. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Lin et al. BMC Nephrology 2014, 15:36 Page 2 of 7
http://www.biomedcentral.com/1471-2369/15/36[4-6]. Hypertension and diabetes have been the leading
causes of CKD in the developed countries. Approxi-
mately 40% of diabetic patients had some degree of CKD
in the United States [7] and 40–50% of diabetic patients
had kidney injury in Japan [8]. Meanwhile, about 25.3%
of patients with hypertension were reported to experi-
ence kidney injury in Turkey [9]. Obesity conferred a
high susceptibility to CKD in Norway with a relative risk
of 1.77 [10].
Metabolic diseases have become major causes of CKD.
Many epidemiological studies have found that geo-
graphic variation may lead to geographic risk factors for
the occurrence of CKD. Geographic attributes may be as
diverse as the physical and socioeconomic characteristics
of a region and the available medical care [11]. As a big
province in a developing country, Zhejiang has its
own geographic attributes, but an epidemiological survey
studying the association between CKD and metabolic
diseases had not been undertaken yet.
Therefore, the purpose of our study was to estimate
the prevalence of CKD in Zhejiang province, with a
focus on the CKD prevalence in individuals with meta-
bolic diseases, and to analyze the associated CKD risk
factors.
Methods
Study design and subjects
Using a multistage, stratified sampling method, we re-
cruited adult (18+) residents of the Zhejiang province to
participate in our cross-sectional survey. First, one urban
district and one rural district were randomly selected
from the eastern and western regions of the province
[12]. Then, from each district, five communities were
randomly selected to serve as the population base for
this study, for a total of 20 communities. The fishing
population of the Zhejiang island was subsequently
added to ensure representation of the province’s diverse
socioeconomic characteristics [13,14]. Finally, we ran-
domly (by simple randomization using SPSS software,
version 19.0) selected 2000–2500 adults from each dis-
trict (Figure 1) as representative samples. The screening
was performed from September 2009 to June 2012. The
ethics committee of Zhejiang University First Hospital
approved the study. All participants were voluntary and
written informed consents were obtained.
Screening protocol and evaluation criteria
All participants were required to complete a question-
naire including gender, age, family income, diet and
medical history, physical examination (height, weight
and blood pressure) and laboratory examination (fasting
blood glucose, serum creatinine, serum lipids, serum
uric acid, urinary albumin and urinary creatinine). All
investigators received unified training before screening.Data testing and collection were completed at the local
central hospital.
Chronic kidney disease
Chronic kidney disease was defined as having an esti-
mated glomerular filtration rate (eGFR) of < 60 mL/min/
1.73 m2 or the presence of albuminuria. Serum creatin-
ine was measured by Jaffe’s kinetic method. The eGFR
level was calculated by the simplified Modification of Diet
in Renal Disease equation [15]. Urinary albumin and urin-
ary creatinine were measured using a spot morning urine
sample. Urinary albumin was measured by the immunotur-
bidimetric method and urinary creatinine was measured by
Jaffe’s kinetic method. The urinary albumin to creatinine ra-
tio (ACR) was calculated. Albuminuria was defined as an
ACR value higher than 30 mg/g. Micro-albuminuria was
defined as an ACR ranging from 30 to 299 mg/g and
macro-albuminuria with an ACR 300 mg/g or greater.
CKD was classified based on the levels of eGFR and ACR
according to KDIGO criteria [16].
Blood pressure measurement
Blood pressure was measured by sphygmomanometer at
least 3 times with at least a 1 minute interval each time.
The mean of these readings was calculated. If the difference
between any two readings was greater than 10 mmHg, the
mean of the closest two readings was used. Hypertension
was defined as a systolic blood pressure (SBP) more than
140 mmHg, a diastolic blood pressure (DBP) more than
90 mmHg, any use of antihypertensive medication in the
past 2 weeks irrespective of blood pressure, or a history of
hypertension.
Fasting blood glucose and other measurements
Fasting blood glucose (FBS) was tested with a glucose
oxidase method. The diagnosis of diabetes mellitus was
established when the FBS was ≥ 7.0 mmol/L, or any use
of oral hypoglycemic agents or insulin. Hyperlipidemia
was defined as total cholesterol more than 5.18 mmol/L,
triglycerides greater than 1.70 mmol/L or pharmacologic
lipid-lowering therapy. Hyperuricemia was defined as a
serum uric acid level greater than 417 mmol/L in males,
or 357 mmol/L in females. Overweight was defined as a
BMI of 25.00 to 29.99 kg/m2, and obesity was defined as
a BMI more than 30.00 kg/m2.
Statistical analysis
Data input and analysis were done by more than two inves-
tigators together who had not participated in the screening.
Continuous variables were presented as means ± SD, and
categorical variables were expressed as proportions with
95% CIs. The standardization prevalence of CKD was
adjusted for age and sex based on the population distribu-
tion in China in 2010. Differences in demographic and
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conditions among participants with and without CKD,
were analyzed using two-tailed unpaired student’s
t-tests for continuous variables and chi-square tests for
categorical variables. We examined risk factors associ-
ated with decreased renal function and albuminuria
using multivariate logistic regression, and the results
were expressed as odds ratios (ORs) with 95% CIs. Age
(by decade), sex, hyperuricemia, diabetes, hyperten-
sion, obesity, hypertriglyceridemic and hypercholester-
olemia as covariates were included in the multivariable
logistic regressions. Statistical significance was setFigure 1 The Map of Zhejiang Province. A, B, C, D, and E were the five
C: western rural district. D: western urban district. E: island.at a P value = 0.05. All analyses were done using the
SPSS 19.0.
Results
Demographic characteristics of the participants
A total of 11,013 people were enrolled in the investiga-
tion, with 10,384 people completing the screening for a
completion rate of 94.3%. The mean age of all partici-
pants was 52.9 ± 14.5 years. The participants with CKD
were older than those without CKD (61.0 ± 14.7 years
versus 51.6 ±14.0 years, P < 0.001). More women suf-
fered with CKD compared with men (64.5 versus 35.5%).districts we chosen. A: eastern rural district. B: eastern urban district.
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cholesterol (TC), triglycerides (TG), uric acid (UA) and
BMI were significantly higher in the CKD group than those
in the non-CKD group, all P values < 0.001 (Table 1).
Prevalence of CKD
The prevalence was gender- and age-adjusted using data
from the population distribution in China in 2010. The
adjusted prevalence of albuminuria was 8.65% (95% CI
7.98–9.31) and that of reduced kidney function was 1.83%
(95% CI 1.52–2.13). The overall prevalence of CKD was
9.88% (95% CI 9.18–10.59). The prevalence of micro-
albuminuria was 7.49% (95% CI 6.88–8.10) and that of
macro-albuminuria was 1.16% (95% CI 0.84–1.30). The
prevalence of ESRD was 0.06% (95% CI 0.01–0.12). The
prevalence of CKD in females was 11.71% (95% CI 10.94–
12.48) which was higher than that in males (8.07%, 95% CI
7.73–8.71), P < 0.001 (Table 2).
The prevalence of CKD differed between geographical
regions in Zhejiang province (Table 3). The prevalence
of albuminuria in the eastern urban district was lower
than that in the eastern rural district (8.31 versus 8.83%,
P < 0.001). However, there was no significant difference
on the prevalence of albuminuria between the urban dis-
trict and rural district in the western Zhejiang province
(P = 0.058). Compared with the other areas, the preva-
lence of reduced renal function in the eastern rural
district was the highest (4.83%, all P values < 0.001). The
prevalence of reduced renal function in western areas
was lower than that in eastern areas (P < 0.001). The res-
idents on the island had a higher prevalence of albumin-
uria; the prevalence of CKD on the island was the
highest in Zhejiang province.Table 1 Clinical features and metabolic characteristics of part
CKD 1 CKD 2 CKD 3A CKD 3
eGFR >90 60-89 45-59 30-44
ACR ≥30 ≥30
Male n(%) 200(30.1%) 153(35.4%) 101(46.8%) 22(53.7
Age (years) 58.3 ± 13.5 61.5 ± 14.7 66.5 ± 16.4 66.8 ±
SBP (mmHg) 146.9 ± 25.7 148.1 ± 25.3 145.2 ± 23.9 149.4 ±
DBP(mmHg) 84.2 ± 13.4 82.6 ± 12.4 79.5 ± 12.2 80.7 ±
FBS(mmol/L) 5.69 ± 2.30 5.36 ± 1.76 5.07 ± 1.56 5.41 ±
TG(mmol/L) 1.70 ± 1.76 1.54 ± 1.09 1.52 ± 1.18 1.83 ±
TC(mmol/L) 5.02 ± 1.08 4.89 ± 0.93 4.97 ± 1.18 4.91 ±
UA(mmol/L) 275.9 ± 80.4 316.2 ± 92.8 364.4 ± 105.0 393.9 ±
BMI(kg/m2) 23.8 ± 3.85 23.5 ± 4.23 23.2 ± 3.49 23.5 ±
eGFR(mL/min/1.73m²) 123.7 ± 28.1 73.7 ± 7.91 54.8 ± 3.82 38.5 ±
ACR(mg/g) 149.7 ± 429.0 196.3 ± 329.6 91.8 ± 259.1 237.2 ±
CKD was defined as eGFR < 60 mL/min/1.73 m2 or albuminuria. Continuous data we
FBS = fasting blood glucose. BMI = body mass index. SBP = systolic blood pressure. D
UA = uric acid. SDs = standard deviations. eGFR = estimated glomerular filtration rate
Non-CKD: no indicators of kidney damage. P*(comparisons among those with CKDAssociated risk factors for CKD
Multivariate analysis by binomial logistic regression
demonstrated that the following factors were independ-
ently associated with the presence of albuminuria: age
(by decade), female, hypertension, diabetes, hyperurice-
mia and obesity (Table 4). Hypercholesterolemia was not
an independent risk factor of micro-albuminuria (OR =
0.93, 95% CI 0.80–1.08, P = 0.317). Only age (by decade),
hyperuricemia and albuminuria were significantly associ-
ated with reduced renal function, all P values < 0.001.
The prevalence of CKD in patients with hypertension
was higher than that in individuals without hypertension
(P < 0.001). Likewise, there were significant differences in
the prevalence of CKD between people with diabetes
and non- diabetics (P < 0.001), obesity and non-obesity
(P < 0.001), hyperuricemia and non-hyperuricemia (P <
0.001). The comparison between patients with hyperlip-
idemia and those without hyperlipidemia showed there
was significant difference in the prevalence of CKD with
presence of hyperlipidemia (10.54 vs 9.27%, respectively,
P < 0.001) (Figure 2).
Discussion
Prevalence of CKD
To the best of our knowledge, this study was the first
epidemiological survey of CKD in Zhejiang province.
The overall prevalence of CKD in Zhejiang province
(9.88%) was lower than results from a national survey
(10.8%). Several cross-sectional studies indicated that the
CKD prevalence differed substantially between geo-
graphical regions in China [17-19]. The prevalence of
CKD in Beijing was 13.0%, which was much higher than
the results we found for Zhejiang province. In the studyicipants
B CKD 4-5 CKD 1-5 no CKD Total P*
<30 <60 ≥60
or ≥30 <30
%) 13(56.5%) 489(35.5%) 3974(44.1%) 4463(43.0%) 0.000
15.1 70.4 ± 10.3 61.0 ± 14.7 51.6 ± 14.0 52.9 ± 14.5 0.000
25.8 161.6 ± 28.9 147.3 ± 25.4 131.2 ± 19.9 133.4 ± 21.4 0.000
14.2 83.4 ± 9.63 82.8 ± 13.0 78.2 ± 10.8 78.8 ± 11.2 0.000
1.08 4.92 ± 0.87 5.47 ± 2.00 5.03 ± 1.14 5.09 ± 1.30 0.000
2.13 1.33 ± 0.71 1.62 ±1.49 1.43 ± 1.60 1.45 ± 1.37 0.000
1.08 4.37 ± 0.08 4.96 ± 1.05 4.79 ± 1.42 4.81 ± 1.37 0.000
113.9 435.9 ± 107.3 308.6 ± 98.1 288.0 ± 86.2 290.7 ± 88.2 0.000
4.22 21.9 ± 3.48 23.6 ± 3.93 23.0 ± 4.00 23.1 ± 3.99 0.000
4.21 16.1 ± 6.62 92.9 ± 37.3 105.8 ± 70.5 104.1 ± 32.7 0.000
448.4 354.1 ± 559.8 159.9 ± 380.7 10.0 ± 8.13 29.9 ± 147.8 0.000
re presented as means ± SDs and proportions for categorical variables.
BP = diastolic blood pressure. TC = total cholesterol. TG = triglycerides.
. ACR = urinary albumin to creatinine ratio. CKD = chronic kidney disease.
and without CKD).
Table 2 Prevalence of chronic kidney disease (CKD) classified by eGFR and albuminuria categories (KDIGO 2012)
eGFR (mL/min
Per 1.73 m²)
A1 A2 A3 Total
n Prevalence (%, 95% CI) n Prevalence (%, 95% CI) n Prevalence (%, 95% CI) n Prevalence (%, 95% CI)
G1 G1 - - 605 4.42(3.95-4.89) 59 0.54(0.37-0.70) 664 4.95(4.45-5.45)
G2 G2 - - 360 2.66(2.30-3.03) 72 0.44(0.29-0.59) 432 3.11(2.71-3.50)
G3 G3 170 1.18(0.93-1.41) 66 0.39(0.24-0.52) 21 0.13(0.05-0.22) 257 1.70(0.40-1.99)
G3a G3a 151 1.04(0.81-1.27) 52 0.29(0.17-0.31) 13 0.09(0.02-0.16) 216 1.42(1.15-1.69)
G3b G3b 19 0.14(0.06-0.22) 14 0.10(0.02-0.16) 8 0.04(0.00-0.09) 41 0.28(0.10-0.30)
G4-5 G4-5 10 0.05(0.01-0.12) 4 0.02(0.00-0.05) 9 0.05(0.00-0.12) 23 0.12(0.02-0.24)
Total Total 180 1.23(0.86-1.48) 1035 7.49(6.88-8.10) 161 1.16(0.93-1.41) 1376 9.88(9.18-10.59)
A1 = Normo-albuminuria: ACR < 30 mg/g; A2 =Micro-albuminuria: ACR 30-300 mg/g; A3 =Macro-albuminuria: ACR > 300 mg/g. The prevalence was adjusted using
the data from the population distribution in China in 2010. CKD was defined as eGFR < 60 mL/min/1.73 m2 or albuminuria. ACR = albumin-to-creatinine ratio;
eGFR = estimated glomerular filtration rate; CKD = chronic kidney disease.
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CKD was 12.5%. In Shanghai, the prevalence of CKD
was 11.8%, which was also higher than our present
study. Besides the differences in study methodology, this
heterogeneity might be related to variability in socioeco-
nomic characteristics. China is a developing country
with 34 provinces, autonomous regions and municipal-
ities. Significant differences in lifestyles, climatic condi-
tions, medical care and economic development between
geographical regions may cause the differences in the
diseases’ prevalence. Xu et al. [20] reported that the preva-
lence of diabetes in Chinese adults increased with economic
development. Wang et al. reported that the prevalence of
CKD varied greatly between geographical regions.
In the analysis of different regions in Zhejiang, the
eastern rural region had a rather high prevalence (4.83%)
of reduced kidney function. In our study, eGFR was cal-
culated using serum creatinine. To confirm these results,
serum creatinine was measured again in the central la-
boratory of Zhejiang University First Hospital, and with
the same results. The differences of socioeconomic sta-
tus (lifestyles, medical insurance and family income) be-




Rural residents (A) 4.83(4.34-5.33)
Urban residents (B) 1.86(1.55-2.17)
Western
Rural residents (C) 0.53(0.36-0.69)
Urban residents (D) 0.42(0.28-0.57)
Island residents (E) 1.88(1.57-2.19)
Prevalence was gender and age adjusted. Eastern: the eastern part of Zhejiang prov
as an ACR >30 mg/g. CKD wasdefined as eGFR < 60 mL/min/1.73 m2 or albuminuriahave led to the variation in CKD [12], but these factors
were not fully captured in our survey and deserve fur-
ther investigation. Additionally, the high prevalence of
hyperuricemia in this region may contribute to the high
prevalence of reduced renal function. We found that the
prevalence of hyperuricemia in the eastern rural region
was greater than that in other regions. Hyperuricaemia
was reported to increase the risk for new-onset kidney
disease [21,22]. The island residents had the highest
prevalence of CKD in Zhejiang province. This may be
because of the high sodium diet and unhealthy lifestyles,
as a survey of lifestyles reported diet on the island of
Zhejiang is typically high in sodium [14]. High sodium
intake is associated with increased micro-albuminuria
and decreased renal function [23].
The risk factors of CKD
Our study suggests that metabolic diseases such as
diabetes, obesity, hypertension, and hyperuricemia were
independent risk factors of CKD. These results are
consistent with previous studies [24,25]. Zhejiang has
undergone rapid social-economic development in the
past decades. A rapid increase in metabolic diseases hassocio-economic disparities
Albuminuria CKD






ince. Western: thewestern part of Zhejiang province .Albuminuria was defined
. Reduced renal function = eGFR < 60 mL/min/1.73 m2.
Table 4 Multivariate logistic regression analysis of factors associated with chronic kidney disease (CKD)
Micro-albuminuria Macro-albuminuria Albuminuria G3- G5
OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P
Age (change by 10 years) 1.36(1.29-1.45) <0.001 1.38(1.20-1.59) <0.001 1.91(1.29-1.44) <0.001 1.90(1.70-2.14) <0.001
Femal 1.79(1.56-2.07) <0.001 1.87(1.33-2.63) <0.001 1.81(1.58-2.06) <0.001 0.98(0.76-1.27) 0.883
Hypertension 2.45(2.11-2.85) <0.001 2.35(1.63-3.40) <0.001 2.44(2.12-2.82) <0.001 1.03(0.78-1.36) 0.820
Diabetes 1.88(1.47-2.41) <0.001 1.94(1.12-3.34) 0.017 1.89(1.49-2.39) <0.001 0.54(0.29-1.02) 0.059
Obesity 1.36(1.10-1.69) 0.005 1.59(1.01-2.51) 0.047 1.39(1.14-1.70) <0.001 0.86(0.55-1.33) 0.490
Hyperuricemia 1.32(1.08-1.62) 0.007 2.22(1.48-3.34) <0.001 1.43(1.19-1.73) <0.001 5.66(4.32-7.42) <0.001
Hypertriglyceridemic 1.06(0.91-1.23) 0.492 0.90(0.62-1.29) 0.556 1.03(0.89-1.20) 0.671 0.89(0.66-1.18) 0.410
Hypercholesterolemia 0.93(0.80-1.08) 0.317 1.39(1.00-1.94) 0.049 0.99(0.86-1.13) 0.839 0.90(0.69-1.18) 0.447
Albuminuria - - - - - - 2.82(2.13-3.73) <0.001
Albuminuria: ACR > =30 mg/g. Micro-albuminuria: ACR30-299 mg/g. Macro-albuminuria: ACR 300 mg/g or more; G3- G5 = eGFR <60 mL/min/1 · 73 m2.
OR = odds ratios.
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styles. Nationwide surveys of hypertension suggested
that the prevalence of hypertension increased from 11.3
to 26.6% in the Chinese adult population ([26,27], and
the prevalence of diabetes increased from 5.5 to 9.7%
[28,29]. It suggests that diabetes has been the most com-
mon underlying cause for CKD [30]. Obesity prevalence
has doubled over the last 3 decades [31], and the rapid
increase in the prevalence of metabolic diseases may re-
sult in an even greater burden of CKD. In our survey,
patients with hypertension, diabetes, obesity and hyper-
uricemia had a higher prevalence of CKD than those
without these diseases. For example, the prevalence of
CKD in diabetics was 15.7%, which was only 7.07%
in non-diabetics. Thus, slowing the rise in metabolicFigure 2 The prevalence of CKD in subjects with different
metabolic diseases. Data were adjusted prevalence. yes = subjects
with the disease. no = subjects without the disease.diseases may be a way of preventing CKD. Nevertheless,
more studies are needed to confirm this hypothesis.
Limitations
Our study has certain limitations and constraints. We
did not measure HDL and LDL in our survey. High LDL
cholesterol may be an independent risk factor of CKD.
Our study also relied on single measurements for eGFR
and albuminuria without repeated examination, because
it was cumbersome and expensive, and that may have
resulted in misclassification of individuals with CKD.
Additionally, the cross-sectional design of the study makes
causal inferences impossible.
Conclusions
CKD is an important public health problem in Zhejiang
province, and metabolic diseases may increase the risk
of CKD in Zhejiang population.
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